InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Chesworth Richard, Directeur Scientifique. Director active across 2 companies, notably Kymera Therapeutics, Inc.. In total, 4 filings have been published. The latest transaction was filed on 27 August 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€574,64833,779 shares@ €17.0120.0092% mcap38.4% of flow
Common Stock
SEC:0001209191-21-053642·
€574,64833,779 shares@ €17.0120.0092% mcap38.4% of flow
Common Stock
SEC:0001209191-21-053642:0·
€922,30954,000 shares@ €17.07980.015% mcap61.6% of flow
Common Stock
SEC:0000899243-21-033638·
€922,30954,000 shares@ €17.07980.015% mcap61.6% of flow
Common Stock
SEC:0000899243-21-033638:0·
4 of 4 declarations
About Chesworth Richard
Chesworth Richard is the Chief Scientific Officer of Kymera Therapeutics, Inc. In this role, he oversees the company's scientific research and development. His expertise is crucial for innovation and the development of new therapies within Kymera Therapeutics, Inc.
